This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "2016-10-19PC DrugAllergySubstance Call Minutes"

From HL7Wiki
Jump to navigation Jump to search
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
  
 
<!-- LOOK FOR THE APPROPRIATE SECTION ****** TO ENTER INFORMATION-->
 
<!-- LOOK FOR THE APPROPRIATE SECTION ****** TO ENTER INFORMATION-->
Back to [[Negation_Requirements]]
+
Back to [[Allergy_%26_Intolerance_Drug_Sub-project]]
 
==Minutes Template==
 
==Minutes Template==
 
===Meeting Information===
 
===Meeting Information===
Line 97: Line 97:
 
'''Minutes/Conclusions Reached:'''<br/>
 
'''Minutes/Conclusions Reached:'''<br/>
 
* Netherlands working with ISO on drug safety db [https://www.knmp.nl/producten-en-diensten/gebruiksrecht-g-standaard/informatie-over-de-g-standaard/the-g-standaard-the-medicines-standard-in-healthcare here]
 
* Netherlands working with ISO on drug safety db [https://www.knmp.nl/producten-en-diensten/gebruiksrecht-g-standaard/informatie-over-de-g-standaard/the-g-standaard-the-medicines-standard-in-healthcare here]
 +
* Note: use case is patient safety, not adverse event reporting
 +
* Record what you know; so if Percocet is the trigger, record "acetaminophen and oxycodone." You can't choose one.
 +
* Confirm: inactive ingredient reactions are very rare; our list will only include active ingredients
 +
* A clinician may record a specific product, but the substance is what goes in the allergy list
 +
* Questions on site discussed. Most are TBD.
 +
* How do we map?
 +
** Ask VA/DoD team to present
 +
* What system?
 +
** SCT does not have MINs in substance hierarchy
 +
** Ask Larry to present IDMP
  
 
===Meeting Outcomes===
 
===Meeting Outcomes===
Line 112: Line 122:
  
 
| width="100%" align="left" style="background:#f0f0f0;"|'''Actions''' ''
 
| width="100%" align="left" style="background:#f0f0f0;"|'''Actions''' ''
 +
* Jay to invite contributors
  
* begin construction of test classes
 
  
 
|-
 
|-
Line 127: Line 137:
  
 
|width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/>
 
|width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/>
*Review test class progress & tooling
+
* get those who have mapped to describe process
 +
* become familiar with candidate systems
 
|}
 
|}
  
 
© 2012 Health Level Seven® International.  All rights reserved.
 
© 2012 Health Level Seven® International.  All rights reserved.

Latest revision as of 14:00, 19 October 2016

Back to Allergy_&_Intolerance_Drug_Sub-project

Minutes Template

Meeting Information

HL7 Negation Requirements Meeting Minutes

Location: Phone

Date: 2016-10-19
Time: 9:00-10:00 ET
Facilitator Jay Lyle Note taker(s) Jay Lyle
Attendee Name Affiliation


y Jay Lyle JP Systems / VA
y Froukje Harkes-Idzinga Nictiz
y Rob Hausam Hausam Consulting
y Serafina Versaggi Versaggi Consulting
y Joe Quinn Optum

Agenda

Agenda Topics

  1. confirm goals
  2. address open questions
  3. identify gaps & tasks

Minutes

Minutes/Conclusions Reached:

  • Netherlands working with ISO on drug safety db here
  • Note: use case is patient safety, not adverse event reporting
  • Record what you know; so if Percocet is the trigger, record "acetaminophen and oxycodone." You can't choose one.
  • Confirm: inactive ingredient reactions are very rare; our list will only include active ingredients
  • A clinician may record a specific product, but the substance is what goes in the allergy list
  • Questions on site discussed. Most are TBD.
  • How do we map?
    • Ask VA/DoD team to present
  • What system?
    • SCT does not have MINs in substance hierarchy
    • Ask Larry to present IDMP

Meeting Outcomes

Actions
  • Jay to invite contributors


Next Meeting/Preliminary Agenda Items
  • get those who have mapped to describe process
  • become familiar with candidate systems

© 2012 Health Level Seven® International. All rights reserved.